Circumvention of early graft-versus-host disease in hemiallogeneic bone marrow transplantation in a case of severe combined immunodeficiency.
D000241:Adenosine / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002869:Chromosome Aberrations; D003968:Diarrhea, Infantile / Q000150:complications; D004912:Erythrocytes / Q000201:enzymology; D004927:Escherichia coli Infections / Q000209:etiology; D005260:Female; D006087:Graft vs Host Reaction; D006650:Histocompatibility Testing; D006801:Humans; D006867:Hydrolases / Q000378:metabolism; D007003:Hypoglycemia / Q000150:complications; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D007223:Infant; D037102:Lectins; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D037102:Lectins; D006867:Hydrolases; D000241:Adenosine